{"disease":{"id":"type-ii-myocardial-infarction","name":"type ii myocardial infarction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04838808","title":"Rivaroxaban in Type 2 Myocardial Infarctions","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"University of Alberta","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}